In vitro α-amylase and α-glucosidase inhibition study of dihydropyrimidinones synthesized via one-pot Biginelli reaction in the presence of a green catalyst
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
38183681
DOI
10.1016/j.bioorg.2023.107085
PII: S0045-2068(23)00746-0
Knihovny.cz E-zdroje
- Klíčová slova
- Biginelli, Green catalyst, Multicomponent, α-Amylase along with α-glucosidase,
- MeSH
- alfa-amylasy metabolismus MeSH
- alfa-glukosidasy * metabolismus MeSH
- barbituráty chemie MeSH
- hypoglykemika farmakologie chemie MeSH
- inhibitory glykosidových hydrolas * chemie MeSH
- katalýza MeSH
- simulace molekulového dockingu MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 1,3-dimethylbarbituric acid MeSH Prohlížeč
- alfa-amylasy MeSH
- alfa-glukosidasy * MeSH
- barbituráty MeSH
- hypoglykemika MeSH
- inhibitory glykosidových hydrolas * MeSH
A green catalyst WELPSA-catalyzed three-component condensation (Biginelli) process involving an aldehyde, barbituric/thiobarbituric/1,3-dimethylbarbituric acid, and urea/thiourea/guanidine hydrochloride in a single pot in presence of a green solvent for the production of DHPM have been presented. The catalyst is reusable and this methodology is scalable. By using the in vitro experiments, the antidiabetic potentiality of synthesized compounds that inhibit α-amylase along with α-glucosidase efficiencies was assessed. All the synthesized compounds except for 4a and 4e, showed the most significant inhibition for α-amylase and α-glucosidase activities. Among the synthesized DHPM compounds, 4c and 4b exhibited significant inhibition profiles compared to the standard antidiabetic drug acarbose. Furthermore, synthesized substances' energy-minimized structures, 3D structures, and DFT calculations were performed using Gaussian 09 software, hybrid models, and MM2 force approaches. Strong hydrogen bonds with amino acid residues Arg-672, Arg-600, Trp-613, Asp-404, Asp-282, and Asp-616 indicate that an α-glucosidase-inhibitory peptide may have hypoglycemic efficacy confirmed by the molecular docking study of the synthesized DHPM.
Citace poskytuje Crossref.org